In critically ill patients with thrombocytopenia and heparin exposure, the presence of anti-PF4/heparin antibody ranges between 10% and 30% [19,20], but the actual incidence of HIT appears to be 1% or less [5,19]. This evidence concerns the gene PF4 and Thrombocytopenia.